Cargando…
State-of-the-art management of nasopharyngeal carcinoma: current and future directions
Nasopharyngeal carcinoma (NPC) is a distinct type of head and neck cancer. Approximately 70% of patients with newly diagnosed NPC present with locally advanced disease. Phase III clinical trials support the addition of chemotherapy to radiotherapy for the initial treatment of these patients. Once me...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361911/ https://www.ncbi.nlm.nih.gov/pubmed/15756250 http://dx.doi.org/10.1038/sj.bjc.6602449 |